Nanomedicine Therapeutics is an international peer-reviewed, open access, online journal.

Aims and Scope

Aims

Nanomedicine Therapeutics is an international, peer-reviewed, open-access journal dedicated to publishing high-quality, innovative research and reviews at the forefront of therapeutic nanomedicine. The journal aims to serve as a premier platform for disseminating groundbreaking discoveries that bridge nanoscale material design and clinical therapeutic applications. Our mission is to accelerate the translation of nanomedical innovations from the laboratory bench to the patient's bedside, addressing unmet clinical needs across a wide spectrum of diseases. Nanomedicine Therapeutics strives to be the journal of first choice for researchers in academia, industry, and clinical practice to share transformative work that defines the future of targeted and intelligent therapeutics.

Scope

The scope of Nanomedicine Therapeutics encompasses the entire pipeline of therapeutic nanomedicine, from the rational design and synthesis of novel biocompatible materials to preclinical evaluation, clinical translation, and the understanding of biological interactions. The journal focuses on interdisciplinary research that integrates principles from chemistry, materials science, biology, engineering, and medicine to create advanced nanoscale systems for disease treatment.

Research topics suitable for publication include, but are not limited to:

• Nanocarrier Design & Drug Delivery: Lipid nanoparticles, polymeric micelles, dendrimers, inorganic nanoparticles, and exosomes for the encapsulation and controlled release of small molecules, biologics, nucleic acids (e.g., short interfering RNA [siRNA], messenger RNA [mRNA]), and gene therapies.
• Targeted Therapeutics & Stimuli-Responsive Systems: Active targeting using ligands (e.g., antibodies, peptides) and passive targeting (e.g., the enhanced permeability and retention [EPR] effect), as well as systems responsive to internal (pH, enzymes, redox) or external (light, magnetic fields, ultrasound) stimuli.
• Diagnostic & Therapeutic Integration (Theranostics): Multifunctional nanoplatforms that combine imaging modalities (optical imaging, magnetic resonance imaging [MRI], computed tomography [CT], photoacoustic imaging) with therapeutic approaches for image-guided therapy and treatment monitoring.
• Immunotherapy & Vaccines: Nanomaterials as adjuvants, antigen delivery vehicles, or immune modulators for cancer immunotherapy, infectious disease vaccines, and the treatment of autoimmune disorders.
• Regenerative Medicine & Tissue Engineering: Nanostructured scaffolds, nanofiber matrices, and bioactive nanomaterial coatings for cell delivery, tissue repair, and regenerative therapies.
• Overcoming Biological Barriers: Strategies to enhance circulation time, overcome mucosal, blood-brain barrier, and tumor microenvironment barriers, and improve cellular uptake.
• Biosafety, Toxicology, & Translation: Studies on biocompatibility, long-term toxicity, pharmacokinetics, pharmacodynamics, biodistribution, immunogenicity, and scalable manufacturing relevant to clinical translation.
• Personalized & Precision Nanomedicine: Nanosystems tailored for patient-specific therapy based on genetic, proteomic, or pathological profiles.
• Novel Therapeutic Modalities: Nanomaterials for photothermal therapy (PTT), photodynamic therapy (PDT), radiotherapy enhancement, and sonodynamic therapy.

Ownership

The journal is owned by OAE Publishing Inc.

Publishing Model

Gold Open Access. All articles published by Nanomedicine Therapeutics are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access.

Copyright and License to Publish

Articles in Nanomedicine Therapeutics are published under a Creative Commons Attribution 4.0 International (CC BY 4.0). The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.

Copyright is retained by authors. Authors are required to sign a License to Publish (which can be downloaded from the journal's Author Instructions), granting Nanomedicine Therapeutics, which identifies itself as the original publisher, exclusive rights to publish their articles, and granting any third party the right to use the articles freely as long as the integrity is maintained and the original authors, citation details and publisher are identified.

Editorial Board

For more information about the editorial team, please refer to Editorial Board.

Editorial Policies

All manuscripts submitted to Nanomedicine Therapeutics should adhere to journal's Editorial Policies.

Peer Review

The journal adheres to rigorous peer review and undergoes single-blind peer review. For more details, please refer to Editorial Process and Peer Review Guidelines.

Publication Ethics Statement

Nanomedicine Therapeutics fully adheres to the Code of Conduct and the Best Practice Guidelines of Committee on Publication Ethics (COPE).

The Editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The Editors of Nanomedicine Therapeutics take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.

Journal Information and Statistics

• Publication model: Gold Open Access
• Frequency: Quarterly
• ISSN: Coming soon.
• Digital archive: Portico

Contact

Please visit Contact Us for details about different queries.